Market Report for PET imaging in the USA
|発行||Black Swan Analysis||商品コード||358793|
|出版日||ページ情報||英文 139 Pages
Positron Emission Tomography (PET) is a radioactive nuclear modality that delivers an image of the metabolic processes in the body. The PET imaging scanner detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide tracer, such as fluorodeoxyglucose (18F - FDG), that has been injected into the body. These positron-labelled isotopes are made using a particle accelerator known as a cyclotron.
To improve the accuracy of the location of the tracer within the body, a Computed Tomography (CT) image is done of the patient either following the initial PET image or at the same time with a PET/CT scanner and a combined, fused, image is generated that is able to deliver a high degree of accuracy on the location and the size of a specific lesion.
PET as a modality was introduced into the US market in the early 1980s, but it was not until 1995 when a PET scanner was able to perform a whole body scan was the utility in oncology realised. The appeal of PET imaging to radiologists and nuclear medics is its ability to provide metabolic information that can be overlaid with a structural CT scan. This makes it the standard of care for staging any patient that has been diagnosed with cancer. This adoption of technology by clinicians has contributed to the establishment and continued growth in the USA in the number of PET scanners and cyclotrons producing the 18F - FDG radiotracer.
This report provides information on the historic and current PET scanner and cyclotron market in the USA. Along with the current known number of PET scanner and cyclotron install bases in the USA, the report also contains a detailed breakdown of these machines; by year of installation, manufacturer and model, specific location and current utilization. Future potential market capacity for these machines is also estimated to the year 2020.
Providing a value-added level of insight from the analysis team at Black Swan, an introduction on PET imaging is given, as well as information on the utilization of PET, development of PET over time, current USA healthcare system and PET reimbursement, market evolution and future developments.
This report is built using data and information sourced from information that Black Swan Analysis already possessed on the information of PET scanners and cyclotrons as an internal source, further research was also instigated to verify locations, models, years and other information required for the details of the PET scanners and cyclotrons in this report. This further research included a wide search of the hospitals and clinics listed in this report, as well as internet research into the PET centres and direct contact with the manufacturers. All of the sources used to generate the data and analysis have been identified in the report.